Genitourinary Cancers | Specialty

Antiandrogen Monotherapy for mCRPC

May 28th 2014

Preventing SREs in Prostate Cancer

May 28th 2014

Role of Imaging in M0 CRPC

May 28th 2014

NCCN and AUA Prostate Cancer Guidelines

May 28th 2014

AUA Castration-Resistant Prostate Cancer Guidelines

May 28th 2014

Introduction: Therapeutic Advances in mCRPC

May 28th 2014

Chemotherapy Underutilized in High-Risk Bladder Cancer

May 22nd 2014

Despite evidence supporting its efficacy, chemotherapy is not routinely administered to patients with muscle-invasive bladder cancer.

Cell-Cycle Gene Test Shows Early Promise in Clear Cell RCC

May 20th 2014

A cell-cycle gene array test demonstrated independent value for predicting metastatic progression after surgery for organ-confined renal cell carcinoma (RCC) of clear cell histology, a retrospective study of patient data showed.

Social Media Vital in Marketing Large Urology Practices

May 18th 2014

In the age of social media, simply having a website isn't enough. To keep existing patients and attract new ones, large urology group practices need to build websites that are connected to social media outlets at every turn, said Peter M. Knapp, Jr, MD.

Physical Activity Linked to Lower Risk of Death from Bladder Cancer

May 18th 2014

Self-reported physical activity significantly improved the odds that a person would not die of bladder cancer, a review of a national health information database showed.

Dr. Mirza on Hematuria and a Bladder Cancer Diagnosis

May 17th 2014

Moben Mirza, MD, assistant professor of urology at the University of Kansas Medical Center, discusses a study presented at the 2014 AUA Annual Meeting that evaluated gender and race variation in the workup of hematuria.

Dr. Rhee Discusses Workplace Violence in Urology Practices

May 17th 2014

Eugene Y. Rhee, MD, chief of urology, Kaiser Permanente, discusses workplace violence in urology practices.

Changes in Urology

May 15th 2014

In urology, we are faced with very difficult and challenging times.

AGS-003 to Be Tested With Sunitinib as RCC Treatment

May 7th 2014

A trial (NCT01582672) that will pair a targeted treatment with a vaccine therapy for firstline treatment of renal cell carcinoma (RCC) is recruiting at the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute.

Dr. Rini on Cytoreductive Nephrectomy in RCC

May 7th 2014

Brian Rini, MD, associate professor, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, discusses the role of cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma (RCC).

State of Urology Discussed by Three Organization Leaders

May 2nd 2014

Richard S. Pelman, MD, Juan A. Reyna, MD, and David F. Penson, MD, all large urology organization leaders, cited managing bureaucracy, PSA screening, and in-office ancillaries as top priorities.

Downregulated Oncogene Raises OS in Obese Patients With RCC

April 25th 2014

Obesity increases the chance that someone will get the clear-cell form of renal cell carcinoma (ccRCC). But once an obese patient has the disease, he's likely to survive longer than a non-obese patient.

Dr. Hsieh Discusses New Treatments for Kidney Cancer

April 25th 2014

James J. Hsieh, MD, PhD, medical oncologist, Memorial Sloan Kettering Cancer Center, gives an overview of emerging treatments for patients with kidney cancer.

Dr. Penson on Advantages/ Disadvantages of Large Urologic Practices

April 17th 2014

David F. Penson, MD, MPH, director, Center for Surgical Quality and Outcomes Research Professor of Urologic Surgery, Paul V. Hamilton, M.D. and Virginia E. Howd Chair in Urologic Oncology, professor of medicine, Vanderbilt University Medical Center, discusses some of the advantages and disadvantages of a large urologic practice.

LUGPA Aims to Help Practices Thrive: Leaders Discuss Progress and Goals

April 1st 2014

During the annual meeting of the Large Urology Group Practice Association (LUGPA) in Chicago in November 2013, the organization's president, Deepak A. Kapoor, MD, completed his 2-year term and handed the gavel to incoming president Juan A. Reyna, MD.